U.S. Army scientists, working with medical technology companies, have successfully tested and used products and techniques that have enabled Army surgeons to replace the severely burned skin of soldiers as well as transplant new hands and even faces.
At Duke University, researchers are studying zebra fish to learn how science and medicine might someday be able to regenerate severed human spinal cords.
These examples one already in practice and the other in the early research stages illustrate the potential that regenerative medicine offers for the future of medical care.
This research aims to go beyond easing the pain of life-threatening illnesses by changing the way diseases affect the body and then eradicating them.
The vast majority of currently available treatments for chronic and/or life-threatening diseases are palliative, Morrie Ruffin, managing director of the Alliance for Regenerative Medicine (ARM), told Healthline.
ARM, based in Washington, D.C., is considered the preeminent global advocate for regenerative and advanced therapies.
Other treatments delay disease progression and the onset of complications associated with the underlying illness, he said. Very few therapies in use today are capable of curing or significantly changing the course of disease.
Regenerative medicine has the unique ability to alter the fundamental mechanisms of disease, and thereby offer treatment options to patients where there is significant unmet medical need.
And it has the potential to address the underlying causes of disease, Ruffin said, representing a new and growing paradigm in human health.
The field encompasses a number of different technologies, including cell, gene, and tissue-based therapies.
Read more: Re-growing teeth and healing wounds without scars
With the Army breakthroughs, government investment was key.
The U.S. Department of Defense (DOD) has invested more than $250 million in regenerative medicine research over the past decade in an effort to make promising technologies available to wounded service members.
Dr. Wendy Dean is medical officer for the Tissue Injury and Regenerative Medicine Project Management Office at the U.S. Army Medical Materiel Development Activity at Fort Detrick, Md., home to the Armys Medical Research and Materiel Command.
Those investments have yielded a stress-shielding surgical bandage, Embrace, to reduce scarring after surgery, Dean told Healthline. The research has also enabled tremendous progress in burn care, allowing surgeons to improve recovery from severe burns with the use of novel skin replacement strategies, such as ReCell spray-on skin, or skin substitutes such as StrataGraft. These skin replacement methods reduce or eliminate the need for donor sites, a frequent request of burn patients.
These revolutionary products were not developed by the Army, Dean said, but were supported with research funding, initially through the Armed Forces Institute of Regenerative Medicine.
The DOD also has invested in hand and face transplantation efforts for service members and civilians whose injuries are so severe that conventional reconstruction is insufficient, she said.
Dean noted that DOD funding has supported 13 hand transplants to date, including a transplant for retired Sgt. Brendan Marrocco in 2012. He was the first service member to survive quadrilateral amputations sustained in combat. The funding also supported eight face transplants.
The Armys goal is to heal those injured in battle.
Regenerative medicine is still young, but it has shown tremendous progress over the last decade, Dean said. Our mission is to make wounded warriors whole by restoring form, function, and appearance. This field offers the best hope to someday fully restore lost tissue with tissue that is structurally, functionally, and aesthetically a perfect match. It may be years before the vision is a widespread reality, but the field is well on its way.
Read more: Regenerative medicine doctor says forget the pills
At Duke University, Kenneth Poss, professor of cell biology, and director of the Regeneration Next initiative, was the senior investigator for a study of spinal cord regeneration in zebra fish.
Those findings were published in November in the journal ScienceDaily.
In my lab, we are researching genetic factors that enable regeneration of tissues such as heart and spinal in nonmammalian animals like zebra fish, Poss told Healthline. A scientist in my lab, Mayssa Mokalled, led a study finding that a gene called connective tissue growth factor [CTGF] is important for spinal cord regeneration in zebra fish after an injury that completely severs the cord.
CTGF is necessary to stimulate cells called glia to form a tissue bridge across the severed parts of the spinal cord an early step in spinal cord regeneration.
Within eight weeks, the scientists found that zebra fish regenerate a severed spinal cord, including nerve cells, and fully reverse their paralysis.
Developing techniques to treat and reverse spinal cord damage, a paralyzing and often fatal injury, is a pressing need in regenerative medicine, Poss said.
Our findings present a step toward understanding which glial cells can be encouraged to help heal the spinal cord, and how to stimulate this activity, he said. This is just the first step in many before the findings could be applied to humans.
Poss is already planning trials with mice that he hopes to start in the next few months. Mice represent an important stage in applying his latest findings, he said.
Read more: Should you store or donate your childs umbilical cord blood?
So, why is regenerative medicine important?
Regenerative medicine seeks ways to re-grow or engineer healthy tissue without the need for transplants, Poss said. On a global scale, theres a tremendous organ shortage, and transplantation is an expensive and nonpermanent solution.
Imagine the number of lives that could be improved if, for example, we could find ways to use the bodys innate healing mechanisms to regenerate heart muscle in patients that are spiraling toward heart failure after a heart attack.
Imagine how many lives could be improved if we could find interventions that restore functional spinal cord tissue and reverse paralysis.
Ruffin of ARM sees a promising future for regenerative medicine.
We will continue to see the development of additional regenerative medicine therapies for a broad number of acute and chronic, inherited and acquired diseases and disorders, he said. Therapies in this area will continue to advance along the regulatory pathway, many of which are entering phase III clinical trials this year.
In fact, in the next two years, we are anticipating a number of U.S. and E.U. approvals in the cell and gene therapy sector, including therapies that address certain types of cancers, debilitating retinal disorders, rare genetic diseases, and autoimmune conditions. We also expect to see sustained investment, which will help fuel growth and product development within this sector.
A number of cell and gene therapies and technology platforms are demonstrating real potential to address areas of significant unmet medical need, Ruffin said.
These include cell therapies for blood cancers and solid tumors; gene therapies for rare genetic diseases as well as chronic conditions; and gene editing for the precise targeting and modification of genetic material of a patients cells to cure a broad range of diseases with a single treatment.
Poss at Duke talked about the ultimate quest.
Regenerative medicine has been most successful in restoring or replacing the hematopoietic tissue that creates blood, he said.
We still lack successful regenerative therapies for most tissues, Poss said. The future of regenerative medicine the holy grail will be stimulating the regeneration of healthy tissue in patients without adding cells or manufactured tissue.
Working out the details of innate mechanisms of regeneration in animals like salamanders, zebra fish, and mice, can inform this approach, he said. So can improvement in factor delivery and genome editing applications to encourage the regeneration of healthy tissue.
Ultimately, Poss said, regenerative medicine will change the toolbox of physicians and surgeons, with major impact on outcomes of diabetes, spinal cord injuries, neurodegenerative disease, and heart failure.
ARM says the public does not realize how far the field has progressed in recent years.
Currently, there are more than 20 regenerative medicine products on the market, Ruffin said, primarily in the therapeutic areas of oncology, musculoskeletal and cardiovascular repair, and wound healing.
More than 800 clinical trials are now underway to evaluate regenerative advanced therapies in a vast array of therapeutic categories, he said.
Were seeing a significant focus on oncology, cardiovascular disease, and neurodegenerative diseases, with more than 60 percent of trials falling into one of these three categories, he added. Even though the majority of people perceive regenerative medicine as something of the future, its actually here and now.
- Stanford Center Hopes to Take Stem Cell and Gene Therapies to a New Level - Sickle Cell Anemia News - August 25th, 2017
- Research reveals how estrogen regulates gene expression - Baylor College of Medicine News (press release) - August 25th, 2017
- In pain? For some, gene studies could provide a quick cure - WRAL.com - August 25th, 2017
- Test reveals possible treatments for disorders involving MeCP2 ... - Baylor College of Medicine News (press release) - August 25th, 2017
- To Protect Genetic Privacy, Encrypt Your DNA - WIRED - August 25th, 2017
- Designer babies the not most urgent concern of genetic medicine - Toronto Star - August 22nd, 2017
- Researcher Seeks to Unravel the Brain's Genetic Tapestry to Tackle Rare Disorder - University of Virginia - August 22nd, 2017
- Study finds that you may be as friendly as your genes - Medical Xpress - August 22nd, 2017
- Id genes play surprise role in cardiac development - Medical Xpress - August 22nd, 2017
- MHRA backs gene therapy in battle with 'bubble baby' disease - The Pharma Letter (registration) - August 22nd, 2017
- This Stock Could Be the Tesla of Healthcare - Madison.com - August 20th, 2017
- Genome Cloaking Preserves Privacy While Enabling Diagnosis ... - PLoS Blogs (blog) - August 20th, 2017
- Genetic test helps people avoid statins that may cause them pain - New Scientist - August 18th, 2017
- What can genetic testing really tell you? - Popular Science - August 18th, 2017
- Vitamin C helps genes to kill off cells that would cause cancer - New Scientist - August 18th, 2017
- Why we should all embrace gene editing in human embryos - The Hill (blog) - August 16th, 2017
- Genomic Medicine Has Entered the Building - Hospitals & Health Networks - August 15th, 2017
- Gene-editing scientists to share $500K Albany Med prize - Albany Times Union - August 15th, 2017
- New Hampshire biologist reacts to gene-editing discovery - The Union Leader - August 15th, 2017
- A New Gene Editing Technique Could Finally Allow Us to Treat ALS - Futurism - August 15th, 2017
- Gene Editing System Revamped to Target RNA Aggregates Found in Inherited ALS - ALS News Today - August 15th, 2017
- Studying How Genes, Environment Contribute to Juvenile Arthritis - UB School of Medicine and Biomedical Sciences News - August 14th, 2017
- Ten Weird Ways Scientists Are Changing the World With Gene Editing - Newsweek - August 13th, 2017
- How Gene Editing And Pig Organs Can End The Human Transplant Shortage - Newsweek - August 13th, 2017
- Researchers use CRISPR to manipulate social behavior in ants - Phys.Org - August 11th, 2017
- MoU signed to commercialise gene therapy in India - Odisha Sun Times - August 11th, 2017
- Human Germline Genome Editing Genetics bodies weigh in on debate with position paper - JD Supra (press release) - August 11th, 2017
- Precision Medicine Market will grow at significant CAGR of 10.5% by 2023 - Markets Insider - August 10th, 2017
- Gene Editing Might Mean My Brother Would've Never Existed - TIME - August 10th, 2017
- Gene Therapy Is Now Available, but Who Will Pay for It? - Scientific American - August 9th, 2017
- Here's Why Editas Medicine Rose as Much as 15.9% Monday - Madison.com - August 9th, 2017
- New Gene Editing Study Raises Possibilities, Questions - Chicago Tonight | WTTW - August 8th, 2017
- Kashmiri doctor helps gene editing of human embryos in US - Hindustan Times - August 6th, 2017
- Early gene-editing holds promise for preventing inherited diseases - The Jerusalem Post - August 6th, 2017
- Childhood Cancer Radiation May Cause Unwanted Gene Mutation in Some - Sioux City Journal - August 5th, 2017
- Study examines altered gene expression in heart failure - Medical Xpress - August 5th, 2017
- Gene Editing for 'Designer Babies'? Highly Unlikely, Scientists Say - New York Times - August 5th, 2017
- 11 Organizations Urge Caution, Not Ban, on CRISPR Germline Genome Editing - Genetic Engineering & Biotechnology News (press release) - August 4th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study - Sioux City Journal - August 4th, 2017
- Embryonic Gene Editing Could Wipe Out Several Conditions, Researchers Say - CBS New York - August 3rd, 2017
- Groundbreaking study demonstrates promise and controversy of gene editing in embryos - ABC News - August 3rd, 2017
- Ben-Gurion University scholars uncover the secret to personalized medicine - The Jerusalem Post - August 3rd, 2017
- Kalter: Gene-editing brings hope - Boston Herald - August 3rd, 2017
- Medicine Is Getting More Precise For White People - FiveThirtyEight - August 3rd, 2017
- Genetic counseling field to rapidly expand - CNBC - August 3rd, 2017
- In US First, Scientists Edit Genes of Human Embryos - New York Times - August 2nd, 2017
- Idhifa Approved for Some With Acute Myeloid Leukemia - Sioux City Journal - August 2nd, 2017
- Gene Editing Is Revolutionizing Medicine but Causing a Government Ethics Nightmare - Newsweek - August 1st, 2017
- Homology Med Bags $83.5M More, Fueling Push For Gene Editing ... - Xconomy - August 1st, 2017
- CRISPR Pioneer Zhang Preaches Extra Caution In Human Gene Editing - Xconomy - August 1st, 2017
- In US first, scientists edit genes of human embryos - Indiana Gazette - August 1st, 2017
- Maryland scientists research gene linked to depression | The ... - The Spokesman-Review - July 31st, 2017
- Gene Markers Can Predict Your Outcome of Cancer or Immune Disease - Technology Networks - July 31st, 2017
- University of Maryland scientists research gene linked to depression - Baltimore Sun - July 29th, 2017
- First Editing of Human Embryos Performed in United States - NBCNews.com - July 29th, 2017
- Stanford Center for Definitive and Curative Medicine to tackle genetic diseases - Scope (blog) - July 29th, 2017
- Sorry, it's all in your genes - Daily Trust - July 29th, 2017
- First US team to gene-edit human embryos revealed - Science Magazine - July 28th, 2017
- US Scientists Modify Genes In Human Embryos Using CRISPR - Swarajya - July 28th, 2017
- Abstracts: Milky Way, Medicine, and More - Undark Magazine - July 28th, 2017
- Big Data Shows Big Promise in Medicine - Bloomberg - July 28th, 2017
- Microdystrophin Gene Therapy Shows Promise in Dogs with Duchenne Muscular Dystrophy, Study Shows - Muscular Dystrophy News - July 28th, 2017
- First editing of human embryos carried out in United States - Reuters - July 27th, 2017
- Two Gene Therapy Approaches Pending Approval from FDA Bring Hope to Mesothelioma Community - MesotheliomaHelp.org (blog) - July 27th, 2017
- Medicine's Movable Feast: What Jumping Genes Can Teach Us about Treating Disease - Scientific American - July 26th, 2017
- 3 Genetics Tests To Improve Prenatal Screening - HuffPost - July 26th, 2017
- Phase 2/3 Trial of Elamipretide to Treat Barth Syndrome Now Enrolling Patients - Mitochondrial Disease News - July 26th, 2017
- Gene therapy to correct surfactant protein B deficiency in newborns - Medical Xpress - July 26th, 2017
- Scientists regenerate retinal cells in mice - Medical Xpress - July 26th, 2017
- Scientists identify gene mutations in smoking-related cancers - Medical Xpress - July 26th, 2017
- Our Unfounded Medical Optimism - Slate Magazine - July 26th, 2017
- Microdystrophin restores muscle strength in Duchenne muscular dystrophy - Medical Xpress - July 26th, 2017
- Stanford announces new Center for Definitive and Curative Medicine - Stanford Medical Center Report - July 25th, 2017
- Regenerative medicine startup Rodeo Therapeutics raises $5.9M for drugs to regenerate tissue - GeekWire - July 25th, 2017
- Stealth BioTherapeutics Initiates Phase 2/3 Study of Elamipretide in Patients With Barth Syndrome - Markets Insider - July 25th, 2017
- Thousands of genes exchanged within microbial communities living on cheese - Phys.Org - July 25th, 2017
- Sernova-HemAcure Consortium Announce Significant Progress in Development of 'First in World' Regenerative ... - GlobeNewswire (press release) - July 24th, 2017
- Helix's Bold Plan to Be Your One Stop Personal Genomics Shop - WIRED - July 24th, 2017
- A New Gene-Altering Cancer Treatment Shows 'Astonishing' Rate of Success - Seeker - July 23rd, 2017
- Scientists provide insight into genetic basis of neuropsychiatric disorders - Medical Xpress - July 22nd, 2017